Lenz & Staehelin with Gyrus Capital on equity investment
Neo Medical, a Swiss technology company specializing in spine surgery, has announced the successful completion of a strategic equity investment, including the conversion of existing shareholder loans. The financing round was led by Gyrus Capital, advised by Lenz & Staehelin, a private equity firm based in Geneva. Including the participation of existing investors, among which founders Vincent Lefauconnier and Jonas Larsson, this landmark round is one of the most significant in the spine industry in the last decade. With this financing round, Neo has secured an additional equity investment of up to $68 million (CHF 58 million) to accelerate its global growth.
Lenz & Staehelin’s team
Lenz & Staehelin’s team comprised partner Andreas Rötheli (pictured) Federico Trabaldo Togna , E. Ipek Yüce , David Di Rosa, Noé Luisoni, Céline Perone, Victor Sellier (all corporate / M&A), Floran Ponce and Maximilien de Ridder (both tax), Sevan Antreasyan and Anne-Laure Laplace (both IP and regulatory)
About the financing
The proceeds will be used to increase Neo’s market share in key regions with an immediate focus on expanding the US business, deploying new, complementary, and disruptive products, and enhancing the capabilities of its unique AI driven augmented reality intraoperative data platform, ADVISE.
